# ICU Medical Inc: Form 10-Q for the period ended Sep 30, 2012

- Company: [ICU Medical Inc](/companies/icui.md) (CIK 883984)
- Form: 10-Q
- Filed: 2012-10-19
- Accepted by EDGAR: Oct 18, 2012, 20:50 ET
- Period: 2012-09-30
- Accession: 0000883984-12-000103
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/883984/000088398412000103/icui0930201210-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/883984/000088398412000103/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-07-01 to 2012-09-30 | $81.4m | us-gaap:Revenues |
| Revenue | 9 months, 2012-01-01 to 2012-09-30 | $234.2m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2012-07-01 to 2012-09-30 | $40.7m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2012-01-01 to 2012-09-30 | $119.5m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2012-07-01 to 2012-09-30 | $40.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2012-01-01 to 2012-09-30 | $114.7m | us-gaap:GrossProfit |
| Research and development | 3 months, 2012-07-01 to 2012-09-30 | $3.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2012-01-01 to 2012-09-30 | $8.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2012-07-01 to 2012-09-30 | $20.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2012-01-01 to 2012-09-30 | $63.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2012-07-01 to 2012-09-30 | $17.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2012-01-01 to 2012-09-30 | $42.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2012-07-01 to 2012-09-30 | $5.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2012-01-01 to 2012-09-30 | $14.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 9 months, 2012-01-01 to 2012-09-30 | $28.9m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2012-07-01 to 2012-09-30 | $0.82 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2012-01-01 to 2012-09-30 | $1.98 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-07-01 to 2012-09-30 | $0.85 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2012-01-01 to 2012-09-30 | $2.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-07-01 to 2012-09-30 | 14,826,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2012-01-01 to 2012-09-30 | 14,613,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2012-01-01 to 2012-09-30 | $40.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2012-01-01 to 2012-09-30 | $13.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2012-01-01 to 2012-09-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2012-09-30 | $127.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-09-30 | $312.6m | us-gaap:AssetsCurrent |
| Total assets | at 2012-09-30 | $412.9m | us-gaap:Assets |
| Current liabilities | at 2012-09-30 | $28.9m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2012-09-30 | $373.0m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | at 2012-10-10 | 14,586,369 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/883984/000088398412000103/icui0930201210-q.htm

Filed Oct 19, 2012.
Source: SEC EDGAR, the filing index for accession 0000883984-12-000103. Last ingested by Listed: Nov 14, 2026, 20:54 ET. No prices; not investment advice.
